Application of Fluorescence In Situ Hybridization Assisted by Fluorescence Microscope in Detection of Her2 Gene in Breast Cancer Patients

Overview

Journal Contrast Media Mol Imaging

Specialty Radiology

Date 2022 Aug 26

PMID 36017025

Authors

Fang Lu

Tingting Zhou

Yan Liu

Liying Song

Bin Zhang

Yuyan Li

Affiliations

Soon will be listed here.

Abstract

In order to study the important factors for evaluating the prognosis of breast cancer patients, a fluorescence microscopy-assisted fluorescence in situ hybridization technique was proposed. Compared with other detection techniques, fluorescence in situ hybridization (FISH) technology assisted by a fluorescence microscope has gradually gained favor in related fields due to its advantages of high detection specificity, high sensitivity, and strong experimental period. Combined with the basic overview of fluorescence microscopy and FISH technology, the advantages and application points of FISH technology assisted by fluorescence microscopy in the detection of the Her2 gene in breast cancer patients were studied and discussed. The results show that IHC can be used as the primary screening for HER2 gene status detection; IHC (2+) and IHC (3+) have false positives, which are related to chromosome 17 polysomy, so FISH should be done to confirm the diagnosis.

Citing Articles

Retracted: Application of Fluorescence In Situ Hybridization Assisted by Fluorescence Microscope in Detection of Her2 Gene in Breast Cancer Patients.

Imaging C Contrast Media Mol Imaging. 2023; 2023:9763619.

PMID: 37502543 PMC: 10371743. DOI: 10.1155/2023/9763619.

References

Shah J, Caoili E, Patton M, Tamhankar S, Myint M, Poruri A . Combined Immunofluorescence (IFA) and Fluorescence In Situ Hybridization (FISH) Assays for Diagnosing Babesiosis in Patients from the USA, Europe and Australia. Diagnostics (Basel). 2020; 10(10). PMC: 7650773. DOI: 10.3390/diagnostics10100761. View

Montero Llopis P, Senft R, Ross-Elliott T, Stephansky R, Keeley D, Koshar P . Best practices and tools for reporting reproducible fluorescence microscopy methods. Nat Methods. 2021; 18(12):1463-1476. DOI: 10.1038/s41592-021-01156-w. View

Oh D, Bang Y . HER2-targeted therapies - a role beyond breast cancer. Nat Rev Clin Oncol. 2019; 17(1):33-48. DOI: 10.1038/s41571-019-0268-3. View

Fehrenbacher L, Cecchini R, Geyer Jr C, Rastogi P, Costantino J, Atkins J . NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2. J Clin Oncol. 2019; 38(5):444-453. PMC: 7007289. DOI: 10.1200/JCO.19.01455. View

Chrzanowska N, Kowalewski J, Lewandowska M . Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors. Molecules. 2020; 25(8). PMC: 7221545. DOI: 10.3390/molecules25081864. View

Gajaria P, Tambe S, Pai T, Patil A, Desai S, Shet T . Dual-color dual-hapten in situ hybridization (D-DISH) - Comparison with fluorescence in situ hybridization (FISH) for HER2/neu testing in breast cancer. Indian J Pathol Microbiol. 2020; 63(2):194-199. DOI: 10.4103/IJPM.IJPM_861_19. View

Jensen S, Thomas P, Christensen I, Balslev E, Hansen A, Hogdall E . Evaluation of analytical accuracy of HER2 status in patients with breast cancer: Comparison of HER2 GPA with HER2 IHC and HER2 FISH. APMIS. 2020; 128(11):573-582. DOI: 10.1111/apm.13076. View

Ren M, Ren J, Cai X, Shen X, Kong J, Dai B . Clinicopathological, immunohistochemical and fluorescence in-situ hybridisation features of early subungual melanoma: an analysis of 65 cases. Histopathology. 2020; 78(5):717-726. DOI: 10.1111/his.14279. View

Yamada M, Kubo M, Yamamoto H, Yamashita N, Kai M, Zaguirre K . Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer. Anticancer Res. 2021; 41(8):4143-4149. DOI: 10.21873/anticanres.15217. View

10.

Liu H, Shi W, Jin Z, Zhuo R, Dong J, Lao Q . Global, regional, and national mortality trends of female breast cancer by risk factor, 1990-2017. BMC Cancer. 2021; 21(1):459. PMC: 8070325. DOI: 10.1186/s12885-021-08217-5. View

11.

Perou C, Sorlie T, Eisen M, van de Rijn M, Jeffrey S, Rees C . Molecular portraits of human breast tumours. Nature. 2000; 406(6797):747-52. DOI: 10.1038/35021093. View

12.

Cassidy A, Jones J . Developments in in situ hybridisation. Methods. 2014; 70(1):39-45. DOI: 10.1016/j.ymeth.2014.04.006. View

13.

Hu J, Kang Y, Chen Y, Liu X, Li X, Liu Q . [Analysis of Aerosol Optical Depth Variation Characteristics for 10 years in Urumqi Based on MODIS_C006]. Huan Jing Ke Xue. 2018; 39(8):3563-3570. DOI: 10.13227/j.hjkx.201710125. View

14.

He J, Mo D, Chen J, Luo L . Combined whole-mount fluorescence in situ hybridization and antibody staining in zebrafish embryos and larvae. Nat Protoc. 2020; 15(10):3361-3379. DOI: 10.1038/s41596-020-0376-7. View

15.

Liu Y, Rollins A, Levenson R, Fereidouni F, Jenkins M . Pocket MUSE: an affordable, versatile and high-performance fluorescence microscope using a smartphone. Commun Biol. 2021; 4(1):334. PMC: 7955119. DOI: 10.1038/s42003-021-01860-5. View

16.

Monroe J, Basheer F, Gibert Y . Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research. Cells. 2021; 10(5). PMC: 8150686. DOI: 10.3390/cells10051132. View

17.

Zhan Z, Li J, Xu K . Detection and Quantification of Two Parasitic Ciliates Boveria labialis and Boveria subcylindrica (Ciliophora: Scuticociliatia) by Fluorescence in situ Hybridization. J Eukaryot Microbiol. 2017; 65(4):440-447. DOI: 10.1111/jeu.12488. View

18.

Ahn S, Woo J, Lee K, Park S . HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation. J Pathol Transl Med. 2019; 54(1):34-44. PMC: 6986968. DOI: 10.4132/jptm.2019.11.03. View

19.

Marino F, Brunelli M, Rossi G, Calabrese G, Calio A, Nardiello P . Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors. Expert Rev Mol Diagn. 2021; 21(2):161-173. DOI: 10.1080/14737159.2021.1887733. View

20.

Leung H, Yeung M, Leung W, Wong K, Tang W, Cho W . The current and future applications of hybridization technologies in anatomical pathology. Expert Rev Mol Diagn. 2021; 22(1):5-18. DOI: 10.1080/14737159.2022.2007076. View